Alzheimer's disease: amino acid levels and brain metabolic status

Gennaro Taibi, Maria Concetta Gueli

    Risultato della ricerca: Article

    43 Citazioni (Scopus)

    Abstract

    Abstract To study brain free amino acids and theirrelation with dementia we measured, by high-performanceliquid chromatography (HPLC), the concentration of eightfree amino acids, amines and related compounds. We usedtemporal cortex (TC) samples obtained from 13 Alzheimer’sdisease (AD) patients and an equal number of agematchedcontrols (AC). The patterns of free amino acids,amines and related compounds showed significant quantitativechanges in AD conditions with respect to healthyones. In Alzheimer patients, lower levels of GABA werefound in the TC (-57 %). Amino acids glutamate (Glu),and aspartate (Asp) concentrations, also appeared significantlyreduced in the TC of AD patients (Glu: -30 %;Asp: -40 %) when compared with controls. The significantgap between methionine (Met: -30 %) and cystathionine(Cysta: ?60 %) levels in TC of AD people tocontrols, might suggest an under/over activity of thetransmethylation and transsulphuration pathways, respectively.Glutamine (Gln) and Urea were an exception to thistrend because their content was higher in AD patients thanin controls. Albeit these compounds may have particularphysiological roles, including the possible mediation ofsynaptic transmission, changes in amino acid levels andrelated compounds (detected in steady state) suggest amodified metabolic status in brains of AD patients thatreveals a reduced function of synaptic transmission.Because several evidences show that patients might displayquite different concentrations of neurotransmitters in brainareas, assessing metabolites in different and well-characterizedAD stages should be investigated further.
    Lingua originaleEnglish
    Numero di pagine0
    RivistaNeurological Sciences
    Volume00
    Stato di pubblicazionePublished - 2013

    Fingerprint

    Alzheimer Disease
    Amino Acids
    Brain
    Aspartic Acid
    Amines
    Glutamic Acid
    Cystathionine
    Glutamine
    Synaptic Transmission
    Methionine
    gamma-Aminobutyric Acid
    Neurotransmitter Agents
    Dementia
    Urea
    Chromatography

    All Science Journal Classification (ASJC) codes

    • Dermatology
    • Clinical Neurology
    • Psychiatry and Mental health

    Cita questo

    Alzheimer's disease: amino acid levels and brain metabolic status. / Taibi, Gennaro; Gueli, Maria Concetta.

    In: Neurological Sciences, Vol. 00, 2013.

    Risultato della ricerca: Article

    @article{2097ee2fa98346bea9482d604981767c,
    title = "Alzheimer's disease: amino acid levels and brain metabolic status",
    abstract = "Abstract To study brain free amino acids and theirrelation with dementia we measured, by high-performanceliquid chromatography (HPLC), the concentration of eightfree amino acids, amines and related compounds. We usedtemporal cortex (TC) samples obtained from 13 Alzheimer’sdisease (AD) patients and an equal number of agematchedcontrols (AC). The patterns of free amino acids,amines and related compounds showed significant quantitativechanges in AD conditions with respect to healthyones. In Alzheimer patients, lower levels of GABA werefound in the TC (-57 {\%}). Amino acids glutamate (Glu),and aspartate (Asp) concentrations, also appeared significantlyreduced in the TC of AD patients (Glu: -30 {\%};Asp: -40 {\%}) when compared with controls. The significantgap between methionine (Met: -30 {\%}) and cystathionine(Cysta: ?60 {\%}) levels in TC of AD people tocontrols, might suggest an under/over activity of thetransmethylation and transsulphuration pathways, respectively.Glutamine (Gln) and Urea were an exception to thistrend because their content was higher in AD patients thanin controls. Albeit these compounds may have particularphysiological roles, including the possible mediation ofsynaptic transmission, changes in amino acid levels andrelated compounds (detected in steady state) suggest amodified metabolic status in brains of AD patients thatreveals a reduced function of synaptic transmission.Because several evidences show that patients might displayquite different concentrations of neurotransmitters in brainareas, assessing metabolites in different and well-characterizedAD stages should be investigated further.",
    author = "Gennaro Taibi and Gueli, {Maria Concetta}",
    year = "2013",
    language = "English",
    volume = "00",
    journal = "Neurological Sciences",
    issn = "1590-1874",
    publisher = "Springer-Verlag Italia",

    }

    TY - JOUR

    T1 - Alzheimer's disease: amino acid levels and brain metabolic status

    AU - Taibi, Gennaro

    AU - Gueli, Maria Concetta

    PY - 2013

    Y1 - 2013

    N2 - Abstract To study brain free amino acids and theirrelation with dementia we measured, by high-performanceliquid chromatography (HPLC), the concentration of eightfree amino acids, amines and related compounds. We usedtemporal cortex (TC) samples obtained from 13 Alzheimer’sdisease (AD) patients and an equal number of agematchedcontrols (AC). The patterns of free amino acids,amines and related compounds showed significant quantitativechanges in AD conditions with respect to healthyones. In Alzheimer patients, lower levels of GABA werefound in the TC (-57 %). Amino acids glutamate (Glu),and aspartate (Asp) concentrations, also appeared significantlyreduced in the TC of AD patients (Glu: -30 %;Asp: -40 %) when compared with controls. The significantgap between methionine (Met: -30 %) and cystathionine(Cysta: ?60 %) levels in TC of AD people tocontrols, might suggest an under/over activity of thetransmethylation and transsulphuration pathways, respectively.Glutamine (Gln) and Urea were an exception to thistrend because their content was higher in AD patients thanin controls. Albeit these compounds may have particularphysiological roles, including the possible mediation ofsynaptic transmission, changes in amino acid levels andrelated compounds (detected in steady state) suggest amodified metabolic status in brains of AD patients thatreveals a reduced function of synaptic transmission.Because several evidences show that patients might displayquite different concentrations of neurotransmitters in brainareas, assessing metabolites in different and well-characterizedAD stages should be investigated further.

    AB - Abstract To study brain free amino acids and theirrelation with dementia we measured, by high-performanceliquid chromatography (HPLC), the concentration of eightfree amino acids, amines and related compounds. We usedtemporal cortex (TC) samples obtained from 13 Alzheimer’sdisease (AD) patients and an equal number of agematchedcontrols (AC). The patterns of free amino acids,amines and related compounds showed significant quantitativechanges in AD conditions with respect to healthyones. In Alzheimer patients, lower levels of GABA werefound in the TC (-57 %). Amino acids glutamate (Glu),and aspartate (Asp) concentrations, also appeared significantlyreduced in the TC of AD patients (Glu: -30 %;Asp: -40 %) when compared with controls. The significantgap between methionine (Met: -30 %) and cystathionine(Cysta: ?60 %) levels in TC of AD people tocontrols, might suggest an under/over activity of thetransmethylation and transsulphuration pathways, respectively.Glutamine (Gln) and Urea were an exception to thistrend because their content was higher in AD patients thanin controls. Albeit these compounds may have particularphysiological roles, including the possible mediation ofsynaptic transmission, changes in amino acid levels andrelated compounds (detected in steady state) suggest amodified metabolic status in brains of AD patients thatreveals a reduced function of synaptic transmission.Because several evidences show that patients might displayquite different concentrations of neurotransmitters in brainareas, assessing metabolites in different and well-characterizedAD stages should be investigated further.

    UR - http://hdl.handle.net/10447/75994

    M3 - Article

    VL - 00

    JO - Neurological Sciences

    JF - Neurological Sciences

    SN - 1590-1874

    ER -